Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Pharmas Seek Probe Into Delays Of Patent-Dispute Decisions

This article was originally published in PharmAsia News

Executive Summary

India's pharmaceutical industry is demanding an investigation into delays in orders of medicines that are involved in patent disputes. The Indian Pharmaceutical Alliance urged the patent office to check on "inordinate delays" in issuing final orders in cases in which its members have challenged patent grants under patent-enforcement regulations. The appeal was issued by the IPA to the controller general of patents, designs and trademarks and the chief patent-enforcement agency. It said several drug makers have taken advantage of delayed decisions, some delayed for at least six months beyond a final hearing. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071133

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel